Olutasidenib (FT-2102) (Synonyms: FT-2102) |
| Catalog No.GC31874 |
Olutasidenib (FT-2102) (FT-2102) es un inhibidor selectivo y penetrante del cerebro altamente potente, activo por vÍa oral, de la isocitrato deshidrogenasa 1 mutante (IDH1), con valores IC50 de 21,2 nM y 114 nM para IDH1-R132H e IDH1-R132C , respectivamente .
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1887014-12-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Olutasidenib is a highly potent, selective inhibitor of mutant Isocitrate dehydrogenase (IDH)1 that could be used in the treatment of acute myeloid leukemia.
[1]. JM Watts, et al. A phase 1 dose escalation study of the IDH1m inhibitor, FT-2102, in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
Average Rating: 5 (Based on Reviews and 6 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *